One hour. That is how long it took for a single 1.8 g dose of Lion's mane mushroom to make healthy young adults measurably faster on a classic attention test. It is the kind of result that sends supplement shelves into a frenzy. But the same study also reported a stress finding that missed statistical significance, along with null and even slightly negative results elsewhere. Here is what the data show, and what they don't.
What Is Lion's Mane, and Why Do Nootropic Fans Care?
Lion's mane (Hericium erinaceus) is a shaggy white edible mushroom used for centuries in East Asian cooking and traditional medicine. Its modern reputation rests on two families of compounds:
- Hericenones, found mainly in the fruiting body (the mushroom you can see).
- Erinacines, found mainly in the mycelium (the root-like network).
In cell and animal research, both groups have been linked to stimulation of nerve growth factor (NGF), a protein involved in the survival and maintenance of neurons. That is the biological story behind the "brain mushroom" nickname. It comes largely from preclinical work, so human trials matter far more than the mechanism.
The Study: Small, Tidy, and Honest About Its Limits
Researchers at Northumbria University in the UK, publishing in Nutrients in 2023, ran a randomized, double-blind, placebo-controlled, parallel-groups pilot study. The key details:
- Participants: 41 healthy adults aged 18-45
- Dose: 1.8 g of Hericium erinaceus
- Acute test: 60 minutes after a single dose
- Chronic test: after 28 days of daily supplementation
- Funding note: the product was supplied by Sempera Organics, which had no role in the study design, data analysis, interpretation, or publication decision
Most Lion's mane research so far has focused on long-term supplementation in people who already have cognitive concerns. This study asked a different question: does it do anything for healthy young brains, and does it work fast?
What Improved
Stroop task speed, one hour after a single dose. Participants who took Lion's mane performed faster on the Stroop task than the placebo group (p = 0.005). The Stroop test asks you to name the ink color of a word while ignoring the word itself (for example, the word "RED" printed in blue). It is a standard measure of attention and cognitive control, so a speed gain here is interesting.
That p-value is solid by conventional standards. But it applies to one outcome at one time point in a small sample.
What Didn't (The Catch)
This is where the clickbait version of the story falls apart.
- The stress result was a trend, not a finding. After 28 days, subjective stress was lower in the Lion's mane group, but the p-value was 0.051, just above the usual 0.05 cutoff. It is a hint, not proof.
- Other measures came up empty. The authors report "null and limited negative findings" across the remaining cognitive and mood outcomes. The abstract doesn't itemize them, but the takeaway is clear: this was not a broad cognitive boost.
- Sample size is small. With 41 people split across two groups, a pilot study can easily produce false positives or miss real effects. The authors themselves urge caution and call for larger trials.
The researchers describe their conclusions as tentative: Lion's mane may improve speed of performance and reduce subjective stress in healthy young adults.
How This Compares to Older-Adult Research
The best-known human work on Lion's mane involved older adults with mild cognitive impairment (MCI), typically using multi-week supplementation. In those studies, researchers looked for gradual improvements on cognitive scales, which fits the idea of a compound supporting neural health over time.
The Northumbria pilot differs in three ways:
- Population: healthy young adults with little room to improve, rather than people with measurable deficits.
- Timeframe: it tested an acute effect at 60 minutes, not only slow, cumulative change.
- Outcome: processing speed on a focused task, not overall cognitive scores.
This matters because healthy young brains tend to show a "ceiling effect." It is harder to improve something that already works well, so modest or inconsistent results are not surprising. An acute effect in this group is also hard to explain by NGF-driven neural growth alone, which presumably takes longer. The mechanism behind the fast Stroop result is unclear.
Practical Takeaways
If this study has piqued your interest, here is how to think about it sensibly.
Dose: The study used 1.8 g per day. That is a reasonable reference point, not a guaranteed sweet spot.
Fruiting body vs. mycelium: Check labels. Fruiting body products are the source of hericenones, while mycelium-based products may differ in composition and often contain leftover grain substrate. The abstract doesn't specify which form was used, so don't assume your product matches the trial's. Look for brands that state the extract type, the amount of mushroom per serving, and ideally third-party testing.
Timing: The one significant result appeared 60 minutes post-dose. If you want to test it yourself, taking it in the morning about an hour before demanding focus work lines up with the study's timeline. That is an inference from the data, not a proven protocol.
Who it might suit: Students and knowledge workers who want to experiment with an inexpensive, generally well-tolerated supplement. It is not a replacement for sleep, exercise, or caffeine.
Realistic expectations:
- Expect, at most, a subtle effect on processing speed, and possibly none.
- Don't expect a dramatic stress reduction; that signal was borderline.
- Give it a fair trial, perhaps four weeks, and judge by your own focus and mood rather than hype.
- Talk to a clinician first if you take medication, are pregnant, or have a mushroom allergy.
The Bottom Line
The headline result is real but narrow: faster Stroop performance one hour after 1.8 g of Lion's mane in a small, well-designed pilot. The 28-day stress benefit did not reach significance, and other outcomes showed nothing or slightly negative effects. Lion's mane is a promising candidate for further research, not a proven cognitive enhancer for healthy young people. Bigger, replicated trials will determine whether this is a genuine nootropic or just a tantalizing blip.
